{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:50:37Z","timestamp":1781848237036,"version":"3.54.5"},"reference-count":27,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014554","name":"Janssen Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014554","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Inhibition of xanthine oxidase with allopurinol increases bone alkaline phosphatase (ALP) in vitro, while ALP promotes bone and vascular mineralization and is linked to reduced survival in general and renal populations. However, clinical associations between allopurinol use and ALP have not yet been reported. We examined prospective associations between allopurinol use, ALP levels, and death in patients with non-dialysis CKD. Population and Setting: A total of 1636 multi-ethnic patients enrolled in the CAN AIM to PREVENT, a 3-year prospective observational study in Toronto, Canada. Primary Outcomes: ALP levels and the combination of renal and patient deaths. Statistical Analyses: Joint generalized structural equation modeling, causal mediation, and controlled direct effects. Results: Allopurinol use was associated with increased ALP (18.3% (95% CI: 10.9, 26.2, p &lt; 0.001)) but not renal and patient death (HR = 1.32 (0.87, 1.99, p = 0.193)). The association between allopurinol and ALP was most pronounced when PTH and urate were low, and was partially mediated by PTH (7.9%, (p = 0.006)). Limitations: Observational and post hoc designs prevent causal inferences. Lack of data about specific ALP isoforms. Conclusions: Allopurinol use was associated with increased ALP but not renal or patient deaths in patients with non-dialysis CKD. Future studies can confirm the generalizability to other clinical populations and examine mechanisms and clinical significance.<\/jats:p>","DOI":"10.3390\/jcm15124685","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:56:31Z","timestamp":1781675791000},"page":"4685","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Allopurinol and Alkaline Phosphatase Levels in Patients with Non-Dialysis CKD"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8736-4779","authenticated-orcid":false,"given":"Hulya","family":"Taskapan","sequence":"first","affiliation":[{"name":"Nephrology Department, University of Toronto, Toronto, ON M5G 2C4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolgay","family":"Taskapan","sequence":"additional","affiliation":[{"name":"Research Department, Kidney Life Sciences Institute, Toronto, ON M5G 2N2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7830-1645","authenticated-orcid":false,"given":"Antonio","family":"Bellasi","sequence":"additional","affiliation":[{"name":"Nephrology Department, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Tam","sequence":"additional","affiliation":[{"name":"Research Department, Kidney Life Sciences Institute, Toronto, ON M5G 2N2, Canada"},{"name":"Nephrology Department, Scarborough Health Network, Toronto, ON M1P 2V5, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5356-872X","authenticated-orcid":false,"given":"Tabo","family":"Sikaneta","sequence":"additional","affiliation":[{"name":"Research Department, Kidney Life Sciences Institute, Toronto, ON M5G 2N2, Canada"},{"name":"Nephrology Department, Scarborough Health Network, Toronto, ON M1P 2V5, Canada"},{"name":"Department of Family and Community Medicine, University of Toronto, Toronto, ON M5S 1A1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1053\/j.ajkd.2013.02.366","article-title":"Bone Alkaline Phosphatase in CKD\u2013Mineral Bone Disorder","volume":"62","author":"Sardiwal","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrneph.2017.60","article-title":"Alkaline phosphatase: A novel treatment target for cardiovascular disease in CKD","volume":"13","author":"Haarhaus","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1359\/jbmr.1997.12.2.210","article-title":"Different Responses of Bone Alkaline Phosphatase Isoforms During Recombinant Insulin-like Growth Factor-I (IGF-I) and During Growth Hormone Therapy in Adults with Growth Hormone Deficiency","volume":"12","author":"Magnusson","year":"1997","journal-title":"J. Bone Miner. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s002239900441","article-title":"Skeletal alkaline phosphatase activity is primarily released from human osteoblasts in an insoluble form, and the net release is inhibited by calcium and skeletal growth factors","volume":"62","author":"Anh","year":"1998","journal-title":"Calcif. Tissue Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1053\/j.ajkd.2013.04.012","article-title":"Prognostic Importance of Serum Alkaline Phosphatase in CKD Stages 3-4 in a Clinical Population","volume":"62","author":"Taliercio","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00223-018-0399-z","article-title":"Alkaline Phosphatases in the Complex Chronic Kidney Disease-Mineral and Bone Disorders","volume":"103","author":"Bover","year":"2018","journal-title":"Calcif. Tissue Int."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Bover, J., Aguilar, A., Arana, C., Molina, P., Lloret, M.J., Ochoa, J., Bern\u00e1, G., Guti\u00e9rrez-Maza, Y.G., Rodrigues, N., and D\u2019Marco, L. (2021). Clinical Approach to Vascular Calcification in Patients with Non-dialysis Dependent Chronic Kidney Disease: Mineral-Bone Disorder-Related Aspects. Front. Med., 8.","DOI":"10.3389\/fmed.2021.642718"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00223-020-00781-5","article-title":"The Non-invasive Diagnosis of Bone Disorders in CKD","volume":"108","author":"Bover","year":"2021","journal-title":"Calcif. Tissue Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","author":"Hruby","year":"1996","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"(2017). Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. Suppl., 7, 1\u201359.","DOI":"10.1016\/j.kisu.2017.04.001"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.ajkd.2021.07.027","article-title":"Diagnostic Accuracy of Noninvasive Bone Turnover Markers in Renal Osteodystrophy","volume":"79","author":"Behets","year":"2022","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0891-5849(01)00610-4","article-title":"Oxidative stress modulates osteoblastic differentiation of vascular and bone cells","volume":"31","author":"Mody","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejphar.2008.03.024","article-title":"Responses of differentiated MC3T3-E1 osteoblast-like cells to reactive oxygen species","volume":"587","author":"Fatokun","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/jcb.22846","article-title":"Hedgehog signaling and osteogenic differentiation in multipotent bone marrow stromal cells are inhibited by oxidative stress","volume":"111","author":"Kim","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e201900306","DOI":"10.1590\/s0102-865020190030000006","article-title":"The effect of graft application and allopurinol treatment on calvarial bone defect in rats1","volume":"34","author":"Deveci","year":"2019","journal-title":"Acta Cir. Bras."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.yexcr.2016.03.004","article-title":"Allopurinol and oxypurinol promote osteoblast differentiation and increase bone formation","volume":"342","author":"Orriss","year":"2016","journal-title":"Exp. Cell Res."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Adamidis, P.S., Florentin, M., Liberopoulos, E., Koutsogianni, A.D., Anastasiou, G., Liamis, G., Milionis, H., and Barkas, F. (2024). Association of Alkaline Phosphatase with Cardiovascular Disease in Patients with Dyslipidemia: A 6-Year Retrospective Study. J. Cardiovasc. Dev. Dis., 11.","DOI":"10.20944\/preprints202401.0093.v1"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"dyw277","DOI":"10.1093\/ije\/dyw277","article-title":"Explanation in causal inference: Developments in mediation and interaction","volume":"45","author":"VanderWeele","year":"2016","journal-title":"Int. J. Epidemiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/1071576021000040673","article-title":"Xanthine Oxidase Mediates Cytokine-induced, but not Hormone-induced Bone Resorption","volume":"37","author":"Kanczler","year":"2003","journal-title":"Free Radic. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ijbiomac.2018.06.047","article-title":"l-Arginine and allopurinol supplementation attenuates inflammatory mediators in human osteoblasts\u2013osteoarthritis cells","volume":"118","author":"Li","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.semarthrit.2019.11.009","article-title":"Beyond urate lowering: Analgesic and anti-inflammatory properties of allopurinol","volume":"50","author":"Schlesinger","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"sfae400","DOI":"10.1093\/ckj\/sfae400","article-title":"Allopurinol use predicts lower low-density lipoprotein cholesterol in patients with pre-dialysis chronic kidney disease\u2014A prospective cohort study","volume":"18","author":"Taskapan","year":"2025","journal-title":"Clin. Kidney J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1464-410X.1987.tb04863.x","article-title":"Parathyroid Hormone and Electrolytes during Longterm Treatment with Allopurinol and Thiazide","volume":"59","author":"Kohri","year":"1987","journal-title":"Br. J. Urol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1210\/endo.138.11.5505","article-title":"The effects of programmed administration of human parathyroid hormone fragment (1\u201334) on bone histomorphometry and serum chemistry in rats","volume":"138","author":"Dobnig","year":"1997","journal-title":"Endocrinology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/path.1711450403","article-title":"The effects of calcium regulating hormones on bone resorption by isolated human osteoclastoma cells","volume":"145","author":"Chambers","year":"1985","journal-title":"J. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jbmr.1547","article-title":"Osteocyte RANKL: New insights into the control of bone remodeling","volume":"27","author":"Xiong","year":"2012","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/ajcn\/61.3.514","article-title":"Calcium homeostasis and bone metabolism during pregnancy, lactation, and postweaning: A longitudinal study","volume":"61","author":"Cross","year":"1995","journal-title":"Am. J. Clin. Nutr."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4685\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:51:15Z","timestamp":1781844675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":27,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jcm15124685"],"URL":"https:\/\/doi.org\/10.3390\/jcm15124685","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]}}}